Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Jubilant Therapeutics Inc.

Clinical trials sponsored by Jubilant Therapeutics Inc., explained in plain language.

Now part of Jubilant Pharmova Limited JUBLPHARMA NSE

Biopharmaceutical company developing small molecule therapies.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Not yet recruiting 1

Can a pill reach the brain and fight tumors?

Disease control Not yet recruiting

This trial tests an oral drug called JBI-778 in people with brain metastases, leptomeningeal disease, or recurrent high-grade glioma. The drug is designed to block a protein that may help tumors grow. The study aims to find the safest dose and see if the drug can shrink tumors or…

Phase: PHASE1, PHASE2 • Sponsor: Jubilant Therapeutics Inc. • Aim: Disease control

Last updated Aug 09, 2026 00:00 UTC